Vincerx Pharma Profitability Analysis

VINC Stock  USD 0.25  0.01  3.85%   
Based on the key profitability measurements obtained from Vincerx Pharma's financial statements, Vincerx Pharma may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in December. Profitability indicators assess Vincerx Pharma's ability to earn profits and add value for shareholders.
 
Net Loss  
First Reported
2019-12-31
Previous Quarter
-1.8 M
Current Value
-7.8 M
Quarterly Volatility
6.6 M
 
Covid
At present, Vincerx Pharma's PB Ratio is projected to increase significantly based on the last few years of reporting. The current year's Net Debt To EBITDA is expected to grow to 0.25, whereas Book Value Per Share is forecasted to decline to 0.50.
For Vincerx Pharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Vincerx Pharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Vincerx Pharma utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Vincerx Pharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Vincerx Pharma over time as well as its relative position and ranking within its peers.
  
Check out World Market Map.
For information on how to trade Vincerx Stock refer to our How to Trade Vincerx Stock guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vincerx Pharma. If investors know Vincerx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vincerx Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.14)
Return On Assets
(0.66)
Return On Equity
(1.42)
The market value of Vincerx Pharma is measured differently than its book value, which is the value of Vincerx that is recorded on the company's balance sheet. Investors also form their own opinion of Vincerx Pharma's value that differs from its market value or its book value, called intrinsic value, which is Vincerx Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vincerx Pharma's market value can be influenced by many factors that don't directly affect Vincerx Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vincerx Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vincerx Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vincerx Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Vincerx Pharma Return On Asset vs. Return On Equity Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Vincerx Pharma's current stock value. Our valuation model uses many indicators to compare Vincerx Pharma value to that of its competitors to determine the firm's financial worth.
Vincerx Pharma is rated third in return on equity category among its peers. It is rated fourth in return on asset category among its peers . At present, Vincerx Pharma's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Vincerx Pharma's earnings, one of the primary drivers of an investment's value.

Vincerx Return On Asset vs. Return On Equity

Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Vincerx Pharma

Return On Equity

 = 

Net Income

Total Equity

 = 
-1.42
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Vincerx Pharma

Return On Asset

 = 

Net Income

Total Assets

 = 
-0.66
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.

Vincerx Return On Asset Comparison

Vincerx Pharma is currently under evaluation in return on asset category among its peers.

Vincerx Pharma Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Vincerx Pharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Vincerx Pharma will eventually generate negative long term returns. The profitability progress is the general direction of Vincerx Pharma's change in net profit over the period of time. It can combine multiple indicators of Vincerx Pharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive IncomeK8.4 K
Operating Income-42.6 M-44.7 M
Income Before Tax-40.2 M-42.2 M
Net Loss-58.8 M-55.9 M
Net Loss-40.2 M-42.2 M
Income Tax Expense-7.4 M-7.8 M
Net Interest Income1.5 M1.6 M
Net Loss-48.9 M-51.3 M
Non Operating Income Net Other-5.3 M-5.6 M
Total Other Income Expense Net2.5 M2.3 M
Interest Income1.5 M798.2 K
Change To Netincome-40.5 K-38.5 K
Net Loss(1.89)(1.98)
Income Quality 1.01  0.58 
Net Income Per E B T 1.01  0.84 

Vincerx Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Vincerx Pharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Vincerx Pharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Vincerx Pharma's important profitability drivers and their relationship over time.

Vincerx Pharma Profitability Trends

Vincerx Pharma profitability trend refers to the progression of profit or loss within a business. An upward trend means that Vincerx Pharma's profit has generally increased over time, and a downward profitability trend means profits are declining. Recognizing problems early in profitability trends allows investors to address revenue and cost issues in advance. Investors and analysts usually monitor three types of profitability trends: gross, operating, and net. Gross profit is the difference between revenue and costs of goods sold. Operating profit is Vincerx Pharma's gross profit minus its overhead. After you account for other unusual revenue, expenses, and costs, you get net profit. Gross profit trends are often a good indicator of future profitability. If you have high gross profit margins, you have a better chance to cover overhead and make money.

Vincerx Pharma Profitability Drivers Correlations

One of the toughest challenges investors face today is learning how to quickly synthesize and read into endless financial statements and information provided by the company, SEC reporting, and various external parties. Understanding the correlation between Vincerx Pharma different financial indicators related to revenue and profit generation helps investors identify and prioritize their investing strategies towards Vincerx Pharma in a much-optimized way. Analyzing correlations between profit drivers that are directly associated with dollar figures is the most effective way to break down Vincerx Pharma's future profitability.

Use Vincerx Pharma in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vincerx Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vincerx Pharma will appreciate offsetting losses from the drop in the long position's value.

Vincerx Pharma Pair Trading

Vincerx Pharma Pair Trading Analysis

The ability to find closely correlated positions to Vincerx Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vincerx Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vincerx Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vincerx Pharma to buy it.
The correlation of Vincerx Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vincerx Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vincerx Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vincerx Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Vincerx Pharma position

In addition to having Vincerx Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Asset Management Thematic Idea Now

Asset Management
Asset Management Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Asset Management theme has 7 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Asset Management Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Vincerx Pharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vincerx Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vincerx Pharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vincerx Pharma Stock:
Check out World Market Map.
For information on how to trade Vincerx Stock refer to our How to Trade Vincerx Stock guide.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
To fully project Vincerx Pharma's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Vincerx Pharma at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Vincerx Pharma's income statement, its balance sheet, and the statement of cash flows.
Potential Vincerx Pharma investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Vincerx Pharma investors may work on each financial statement separately, they are all related. The changes in Vincerx Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Vincerx Pharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.